"Antigens, CD1d" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major histocompatibility complex class I-like protein that contains an IMMUNOGLOBULIN C1-SET DOMAIN. It plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.
| Descriptor ID |
D055610
|
| MeSH Number(s) |
D23.050.301.264.035.100.500 D23.050.301.264.894.080.500 D23.101.100.110.100.500 D23.101.100.894.080.500
|
| Concept/Terms |
Antigens, CD1d- Antigens, CD1d
- CD1d Antigens
- CD1d Antigen
- Antigen, CD1d
- Cd1d Molecule
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD1d".
- Chemicals and Drugs [D]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Antigens, CD1 [D23.050.301.264.035.100]
- Antigens, CD1d [D23.050.301.264.035.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- Antigens, CD1 [D23.050.301.264.894.080]
- Antigens, CD1d [D23.050.301.264.894.080.500]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Antigens, CD1 [D23.101.100.110.100]
- Antigens, CD1d [D23.101.100.110.100.500]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- Antigens, CD1 [D23.101.100.894.080]
- Antigens, CD1d [D23.101.100.894.080.500]
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD1d".
This graph shows the total number of publications written about "Antigens, CD1d" by people in this website by year, and whether "Antigens, CD1d" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD1d" by people in Profiles.
-
Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells. Proc Natl Acad Sci U S A. 2024 Aug 20; 121(34):e2321686121.
-
ER stress in antigen-presenting cells promotes NKT cell activation through endogenous neutral lipids. EMBO Rep. 2020 06 04; 21(6):e48927.
-
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. Nat Commun. 2020 04 14; 11(1):1806.
-
Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist. Org Biomol Chem. 2019 01 31; 17(5):1225-1237.
-
Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect. J Immunol. 2015 Sep 15; 195(6):2710-21.
-
Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas. J Neurooncol. 2014 Nov; 120(2):293-301.
-
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33.
-
Innate PLZF+CD4+ a? T cells develop and expand in the absence of Itk. J Immunol. 2014 Jul 15; 193(2):673-87.
-
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clin Immunol. 2013 Oct; 149(1):55-64.
-
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol. 2011 Aug; 140(2):119-29.